Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Oncology
Prevalence
75.0 / 100K
Incidence
47.0 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Stage IIIA Non-Small Cell Lung Cancer AJCC v7?
There are 2 clinical trials targeting Stage IIIA Non-Small Cell Lung Cancer AJCC v7 tracked by BioSniper.
What is the prevalence of Stage IIIA Non-Small Cell Lung Cancer AJCC v7?
The estimated prevalence of Stage IIIA Non-Small Cell Lung Cancer AJCC v7 is approximately 75.0 per 100,000 population.
Deep-dive into Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis